MIGRAFIT Testing a Group Therapy with Exercise, Muscle Relaxation, and Education for Teens Aged 13 to 17 With Migraine

What this Trial Is About

Migraine is a common headache disorder in children and adolescents that can significantly impact school performance and quality of life. This research aims to evaluate a new group therapy program combining physical activity, progressive muscle relaxation PMR, and psychoeducation tailored for young people aged 13 to 17 years with migraine. The study is a randomized controlled trial designed to assess this non-drug approach and its potential benefits. Participants are randomly assigned to one of two groups the intervention group receives an 18-week program with weekly 65-minute group sessions including high-intensity interval training HIIT followed by PMR, plus two psychoeducation sessions focused on pain management. The control group does not receive any intervention during this time. This design allows comparison of the combined therapy against no treatment. During the study, participants will track their migraine frequency, duration, intensity, and medication use using standardized headache diaries before and after the intervention. Additional assessments include measuring migraine-related disability with a questionnaire and analyzing physical activity patterns in some participants. The study will also evaluate how feasible and acceptable the therapy is from the patient perspective. Total participation covers the treatment and observation period up to 4 weeks after enrollment.

MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine